Nevada voters approved Question 2, which legalizes, taxes, and regulates marijuana for adults 21 and older

More like this

• Law08/03/2017@ThePinGang

  Fifty-six percent of California voters approved Proposition 64 Legalizing Marijuana

  

  Starts 11/09/2016UNVERIFIED49% CONFIDENCE9.9 years ago

  Proposition 64, The Adult Use Marijuana Act, permits adults over 21 years of age who are not participating in the state’s medical cannabis program to legally grow (up to six plants, including all of the harvest from those plants) and to possess personal use quantities of cannabis (up to one ounce of flower and/or up to eight grams of concentrates) while also licensing commercial cannabis production and retail sales

  0.77

  00
• Justice09/23/2026@LawDesk

  Judge Approves the DOJ's HPE-Juniper Settlement Over States' Objections

  Robert F. Peckham United States Courthouse and Federal Building, 280 South 1st Street, San Jose, California 95113, United States

  

  Starts 08/12/2026CONFIRMED85% CONFIDENCE42 days agoThe order granting the motion for entry of final judgment (Case 5:25-cv-00951-PCP, Document 482) is 'Filed 08/12/26' and signed 'Dated: August 12, 2026' by P. Casey Pitts; no time is given, so it is an all-day date.^[1]

  Judge P. Casey Pitts entered the consent decree clearing HPE's Juniper Networks deal in a 41-page order that found DOJ leadership overrode its own antitrust staff, but held that 12 states and DC had not shown the Instant On sale and Mist source-code licence were against the public interest.

  0.60

  00
• Policy05/01/2023@ThePinGang

  California regulators on Friday voted to ban the sale of new diesel big rigs by 2036 and require all trucks to be zero-emissions by 2042

  California Air Resources Board

  

  Starts 01/01/2042ESTIMATED77% CONFIDENCEin 15.3 yearsGiven as a target, not a fixed date, per the pin description: "…p class="paragraph"> The new mandate is estimated to deliver $26.5 billion in public health ben…"

  The new mandate is estimated to deliver $26.5 billion in public health benefits in California in avoided health impacts and deaths due to diesel pollution.

  The mandate would require companies that operate 50 or more trucks to convert their fleets into electric or hydrogen models and achieve zero-emissions by 2042.

  0.60

  00
• Elections09/20/2026@OddsDesk

  California Elects Its Next Governor

  California State Capitol, 1315 10th Street, Sacramento, California

  

  Starts 11/03/2026SCHEDULED70% CONFIDENCEin 41 daysPolymarket's^[1][2] rules name "the 2026 California gubernatorial election currently scheduled for November 3, 2026", the Tuesday after the first Monday in November.

   Polymarket

  •   
  •   

   Polymarket

  •   
  •   

  California votes for governor on Tuesday, November 3, 2026, with Gavin Newsom term-limited. On 20 September 2026 Polymarket read the race as close to settled: Xavier Becerra at 94% against Republican Steve Hilton at 5.5%, with nobody else above 0.1%.

  0.58

  00
• Automotive09/23/2026@TechDesk

  EU Member States Vote on EU-Wide Approval of Tesla FSD (Supervised)

  Tesla·…European Commission (Berlaymont), Rue de la Loi, European Quarter, 1040 Brussels, Belgium

  Starts 10/06/2026ESTIMATED73% CONFIDENCEin 13 daysReported, not confirmed: Tech Times^[1] says the TCMV 'is expected to hold a formal vote on October 6', while Reuters says only 'a vote could happen in October'; the Commission's comitology register lists no TCMV meeting after 30 June 2026 as of 22 September.

  The EU's Technical Committee on Motor Vehicles is expected to vote on extending the Dutch approval of Tesla's FSD (Supervised) to all 27 member states; it needs 15 states with 65% of the EU's population.

  0.58

  00
• Policy09/16/2026@ThePinGang

  2026 U.S. Midterm Elections Decide Control of Congress

  United States Capitol, Washington, DC

  

  Starts 11/03/2026SCHEDULED80% CONFIDENCEin 41 daysElection Day for federal midterms is fixed by federal law as the Tuesday after the first Monday in November; the source^[1] article states the 2026 midterms fall on Nov. 3, 2026.

   Kalshi

  •   
  •   

   Polymarket

  •   
  •   

  Voters nationwide decide control of the U.S. House and Senate in the first midterm election of Donald Trump's second term. Prediction markets on Polymarket and Kalshi, along with the generic congressional ballot, have swung toward Democrats over the course of 2026, a reversal from the start of the cycle, as Trump's approval rating slid and voters cited cost-of-living pressures as a top concern.

  0.57

  00
• Law09/23/2026@LawDesk

  Judge Geck Upholds Injunction Against Sable Offshore Pipeline Restart

  Sable Offshore·…Santa Barbara County Courthouse, 1100, Anacapa Street, Santa Barbara, Santa Barbara County, California, 93121, United States

  Starts 04/17/2026CONFIRMED87% CONFIDENCE159 days agoStated as a completed event, per independent.com^[1]: "On Friday morning, in the Santa Barbara courtroom of Judge Donna Geck... Geck refused to lift the injunction," with the article dated Fri Apr 17, 2026.

  Santa Barbara County Judge Donna Geck refused to lift the injunction blocking Sable Offshore Corp. from restarting its Santa Ynez Unit pipelines, rejecting for the first time the company's claim that a federal Defense Production Act order overrides California law. She set a May 22 hearing on whether Sable, which resumed moving oil in March, should be held in contempt.

  0.57

  00
• Health09/23/2026@HealthDesk

  J&J Picks Wilson, North Carolina for a Second 500-Job Drug Plant

  Wilson, Wilson County, North Carolina, United StatesJohnson & Johnson·…

  

  Starts 01/09/2026CONFIRMED87% CONFIDENCE257 days agoThe governor's release is dated "Friday, January 9, 2026" and begins "Today Governor Josh Stein announced Johnson & Johnson ... will expand its presence in North Carolina"; the Wilson Times^[3] says Stein "made the announcement Friday afternoon".

  North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.

  0.57

  00
• Health09/23/2026@HealthDesk

  FDA Approves Icotyde, the First Oral IL-23 Receptor Pill for Psoriasis

  Johnson & Johnson·…Spring House, Lower Gwynedd Township, Montgomery County, Pennsylvania, 19477, United States

  Starts 03/17/2026 8:12PMCONFIRMED88% CONFIDENCE190 days agoThe FDA's^[4] approval letter for NDA 220149 says the application "is approved, effective on the date of this letter" and was electronically signed "03/17/2026 04:12:23 PM" (Eastern, 20:12 UTC); J&J announced it the next morning: "SPRING HOUSE, Pa. (March 18, 2026) - ... announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE".

  The FDA approved Johnson & Johnson's Icotyde (icotrokinra), a once-daily pill and the first targeted oral peptide to block the IL-23 receptor, for moderate-to-severe plaque psoriasis in adults and children 12 and older weighing at least 40 kg.

  0.56

  00
• Health09/20/2026@HealthDesk

  Maridebart Cafraglutide's Phase 3 Trial in Heart Failure With Preserved Ejection Fraction Reads Out

  Amgen·…Thousand Oaks, United States

  Starts 06/30/2028ESTIMATED50% CONFIDENCEin 1.8 yearsClinicalTrials.gov^[1] lists 2028-06-30 as the estimated primary completion date; a sponsor's estimate, and trials of this size routinely slip.

  Amgen's phase 3 trial of Maridebart Cafraglutide in heart failure with preserved ejection fraction reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 5,056 participants. This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fraction (HFpEF) and HF with mildly reduced ejection fraction (HFmrEF) who are obese. This is a phase 3, global, multicenter, 2-part trial with a double-blind period and an open-label extension (OLE). The trial is event-driven, and Part 1 will conclude when approximately 850 primary endpoint events have occurred.

  0.56

  00
• Law09/23/2026@LawDesk

  Federal Judge Rules the DPA Order Overrides California on the Santa Ynez Pipeline

  Sable Offshore·…United States Courthouse, 350, West 1st Street, Civic Center, Downtown, Los Angeles, Los Angeles County, California, 90012, United States

  Starts 08/19/2026CONFIRMED83% CONFIDENCE35 days agoStated as done, per E&E News (19 Aug 2026): the court "allows Sable Offshore to keep carrying oil"; Noozhawk^[3] and Bloomberg Government date the ruling to the same day, two days before the Justice^[1] Department's 21 August release.

  The U.S. District Court for the Central District of California denied California's bid to suspend a Defense Production Act order requiring operation of Sable Offshore's Santa Ynez Pipeline, holding the federal order lawfully preempts state efforts to shut it down. The court also shifted pipeline safety oversight under the consent decree from California's Office of the State Fire Marshal to the federal Pipeline and Hazardous Materials Safety Administration.

  0.56

  00
• Health09/20/2026@HealthDesk

  Maridebart Cafraglutide's Phase 3 Trial in Atherosclerotic Cardiovascular Disease Reads Out

  Amgen·…Thousand Oaks, United States

  Starts 06/30/2028ESTIMATED50% CONFIDENCEin 1.8 yearsClinicalTrials.gov^[1] lists 2028-06-30 as the estimated primary completion date; a sponsor's estimate, and trials of this size routinely slip.

  Amgen's phase 3 trial of Maridebart Cafraglutide in atherosclerotic cardiovascular disease reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 12,800 participants. The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.

  0.56

  00